한미약품은 연구 개발에 대한 끊임없는 열정으로 글로벌 신약 개발을 위해 노력하고 있습니다.

Armed with a passion for R&D, Hanmi continues its drive to develop innovative drugs.

‘Respect for Human Life’ and ‘Value Creation’ are two core values that are important to Hanmi, and we uphold them via our scientific research and achievements. Hanmi continues to show the highest R&D investment-to-revenue among listed healthcare companies in Korea.

2019 Sales 1113 Bil. Won2019 R&D investment 209 Bil. Won Ratio of R&D investment 18.4%Ratio of R&D investment 18.8%